Business Context and Reporting Period
Company: Tempest Therapeutics, Inc. (TPST)
Filing Type: Form 8-K (Current Report)
Date of Report: February 11, 2026
Reporting Period: Single event date (February 11, 2026)
Business Context: The filing discloses the release of an updated corporate presentation dated February 2026 under Regulation FD (Item 7.01). The presentation is available on the company's investor website and is attached as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely as a notice of the availability of an investor presentation and does not contain audited or unaudited financial statements.
Material Changes
No material changes to financial performance or operations are reported within the text of this filing. The only reported event is the dissemination of new corporate information via an updated presentation.
Guidance, Outlook, and Risks
Management Commentary: The company intends to post an updated corporate presentation to its website. The content of this presentation is incorporated by reference but is explicitly stated not to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liabilities of that section.
Risks and Contingencies: The filing text does not disclose specific new risks, contingencies, or unusual items beyond the standard regulatory disclaimer regarding the status of the attached presentation.
Investor Verification Checklist
- Verify the content of the "Investor Presentation dated February 2026" (Exhibit 99.1) attached to the filing for specific operational or financial updates.
- Confirm the presentation is accessible on the "News, Events & Presentations" subsection of the company's investor website (www.tempesttx.com).
- Note that the presentation is furnished, not filed, and may not carry the same legal liability protections as a formal SEC filing.